A detailed history of Choreo, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Choreo, LLC holds 1,422 shares of UTHR stock, worth $530,249. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,422
Previous 1,054 34.91%
Holding current value
$530,249
Previous $335,000 51.94%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$311.04 - $363.55 $114,462 - $133,786
368 Added 34.91%
1,422 $509,000
Q2 2024

Aug 06, 2024

BUY
$228.26 - $319.04 $240,586 - $336,268
1,054 New
1,054 $335,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.